Fracture Risk Associated with Tirzepatide: A Systematic Review and Meta-analysis of Randomized Controlled Trials and Real-World Evidence

Related

• Genetically proxied GIP pathway links to lower fracture risk

  Diabetes, Obesity & Metabolism · 4 Oct 2026

• Diabetes and low muscle mass concentrate vertebral fractures

  Frontiers in Public Health · 4 Oct 2026

• Retatrutide reduces bodyweight in obesity and type 2 diabetes

  Lancet · 4 Oct 2026

• SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs

  Diabetes & Vascular Disease Research · 4 Oct 2026